At the news
? MIXEDIMPACT 6/10 PRESS-RELEASE filed Apr 23, 2026 at 16:15 ET
Chemed Corp. reported Q1 2026 EPS of $4.84 (GAAP) and $5.65 (Adjusted), missing the $5.30 consensus by 6.6%. Revenue rose 1.6% to $657.5M, slightly above estimates. The company raised full-year 2026 adjusted EPS guidance to $24.00–$24.75 (vs. prior $23.25–$24.25), citing strong VITAS performance and share repurchases, while lowering Roto-Rooter EBITDA margin outlook due to higher marketing costs.
- GAAP EPS of $4.84 missed $5.30 consensus by 8.7%
- Adjusted EPS of $5.65 beat consensus by 6.6%
- Revenue of $657.5M (1.6% YoY growth) slightly above $649.8M estimate
- VITAS revenue up 3.1%, ADC up 2.2%, admissions up 6.9%
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access